Topics

Bayer partners with Evotec for the third time, in polycystic ovary syndrome

14:40 EST 15 Jan 2020 | Elsevier Business Intelligence

For the third time, Bayer AG and Evotec SE are collaborating, this time in a five-year, multi-target agreement to develop can...

Original Article: Bayer partners with Evotec for the third time, in polycystic ovary syndrome

NEXT ARTICLE

More From BioPortfolio on "Bayer partners with Evotec for the third time, in polycystic ovary syndrome"

Quick Search

Relevant Topics

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...